Shares of MiMedx Group (NASDAQ: MDXG) are up 32% at 12:51 p.m. EDT after its board of directors reached an agreement with one of the company's largest shareholders, Prescience Point Capital Management, to revamp the wound-care company's board.
Continue Reading Below
Six new directors will be nominated. Three of them are Prescience Point's nominees, including the new chairwoman, M. Kathleen Behrens Wilsey. MiMedx's new CEO, Timothy R. Wright, is also included in the board refreshment.
Investors are clearly hoping this board refreshment is a sign that the company can turn things around. Prescience Point has been known to open short positions in companies, so the fact that the investment fund is backing the company and not turning against it is a good sign that at least one large investor thinks there's some value left to be had.
While the board refreshment is a good start, it's hard to know how quickly MiMedx can fix its internal issues. With many unknowns, MiMedx remains a risky investment even if it is substantially cheaper than it was a year ago.
The company also has to get the new board past shareholders. Former CEO Parker Petit has nominated himself and two others to the board, so there may be a proxy fight coming. Of course, based on investors' enthusiasm today, garnering the votes to seat MiMedx and Prescience Point's slate seems like the easy part of the turnaround.
10 stocks we like better than MiMedx GroupWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and MiMedx Group wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of March 1, 2019